Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Screening for Anal Cancer in Women With High-grade Vulvar Dysplasia or Vulvar Cancer.

NCT03061435 is registered in ClinicalTrials.gov with Dr. Danielle Vicus as lead sponsor.

NCT NCT03061435
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03061435 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Screening for Anal Cancer in Women With High-grade Vulvar Dysplasia or Vulvar Cancer.
Lead sponsor
Dr. Danielle Vicus
Phase
Not applicable
Overall status
Recruiting
Start date
February 1, 2021
Completion date
January 1, 2026
Enrollment
110 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anal cancer, anal dysplasia, cervical cancer, cervical dysplasia, hpv-related anal squamous cell carcinoma, vulvar cancer, vulvar dysplasia